References
- Cossart P, Sansonetti PJ. 2004. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304: 242-248. https://doi.org/10.1126/science.1090124
- Schroeder GN, Hilbi H. 2008. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 21: 134-156. https://doi.org/10.1128/CMR.00032-07
- Ashida H, Ogawa M, Mimuro H, Kobayashi T, Sanada T, Sasakawa C. 2011. Shigella are versatile mucosal pathogens that circumvent the host innate immune system. Curr. Opin. Immunol. 23: 448-455. https://doi.org/10.1016/j.coi.2011.06.001
- Bhavsar AP, Guttman JA, Finlay BB. 2007. Manipulation of host-cell pathways by bacterial pathogens. Nature 449: 827-834. https://doi.org/10.1038/nature06247
- Ogawa M, Handa Y, Ashida H, Suzuki M, Sasakawa C. 2008. The versatility of Shigella effectors. Nat. Rev. Microbiol. 6: 11-16. https://doi.org/10.1038/nrmicro1814
- Parsot C. 2009. Shigella type III secretion effectors: how, where, when, for what purposes? Curr. Opin. Microbiol. 12: 110-116. https://doi.org/10.1016/j.mib.2008.12.002
- Brennan DF, Barford D. 2009. Eliminylation: a posttranslational modification catalyzed by phosphothreonine lyases. Trends Biochem. Sci. 34: 108-114. https://doi.org/10.1016/j.tibs.2008.11.005
- Puhar A, Tronchere H, Payrastre B, Nhieu GT, Sansonetti PJ. 2013. A Shigella effector dampens inflammation by regulating epithelial release of danger signal ATP through production of the lipid mediator PtdIns5P. Immunity 39: 1121-1131. https://doi.org/10.1016/j.immuni.2013.11.013
- Zurawski DV, Mitsuhata C, Mumy KL, McCormick BA, Maurelli AT. 2006. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Infect. Immun. 74: 5964-5976. https://doi.org/10.1128/IAI.00594-06
- Zurawski DV, Mumy KL, Faherty CS, McCormick BA, Maurelli AT. 2009. Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Mol. Microbiol. 71: 350-368. https://doi.org/10.1111/j.1365-2958.2008.06524.x
-
Arbibe L, Kim DW, Batsche E, Pedron T, Mateescu B, Muchardt C, et al. 2007. An injected bacterial effector targets chromatin access for transcription factor NF-
${\kappa}B$ to alter transcription of host genes involved in immune responses. Nat. Immunol. 8: 47-56. https://doi.org/10.1038/ni1423 - Kramer RW, Slagowski NL, Eze NA, Giddings KS, Morrison MF, Siggers KA, et al. 2007. Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog. 3: e21. https://doi.org/10.1371/journal.ppat.0030021
- Harouz H, Rachez C, Meijer BM, Marteyn B, Donnadieu F, Cammas F, et al. 2014. Shigella flexneri targets the HP1gamma subcode through the phosphothreonine lyase OspF. EMBO J. 33: 2606-2622. https://doi.org/10.15252/embj.201489244
- Geiss-Friedlander R, Melchior F. 2007. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8: 947-956. https://doi.org/10.1038/nrm2293
- Gill G. 2004. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18: 2046-2059. https://doi.org/10.1101/gad.1214604
- Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, Corbett AH. 2007. Classical nuclear localization signals: definition, function, and interaction with importin alpha. J. Biol. Chem. 282: 5101-5105. https://doi.org/10.1074/jbc.R600026200
- Kim JH, Lee JM, Nam HJ, Choi HJ, Yang JW, Lee JS, et al. 2007. SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells. Proc. Natl. Acad. Sci. USA 104: 20793-20798. https://doi.org/10.1073/pnas.0710343105
- Kim DW, Lenzen G, Page AL, Legrain P, Sansonetti PJ, Parsot C. 2005. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitinconjugating enzymes. Proc. Natl. Acad. Sci. USA 102: 14046-14051. https://doi.org/10.1073/pnas.0504466102
- Neumann C, Fraiture M, Hernandez-Reyes C, Akum FN, Virlogeux-Payant I, Chen Y, et al. 2014. The Salmonella effector protein SpvC, a phosphothreonine lyase is functional in plant cells. Front. Microbiol. 5: 548.
- Mazurkiewicz P, Thomas J, Thompson JA, Liu M, Arbibe L, Sansonetti P, Holden DW. 2008. SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogenactivated protein kinases. Mol. Microbiol. 67: 1371-1383. https://doi.org/10.1111/j.1365-2958.2008.06134.x
- Ribet D, Hamon M, Gouin E, Nahori MA, Impens F, Neyret-Kahn H, et al. 2010. Listeria monocytogenes impairs SUMOylation for efficient infection. Nature 464: 1192-1195. https://doi.org/10.1038/nature08963
- Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, et al. 2000. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290: 1594-1597. https://doi.org/10.1126/science.290.5496.1594
- Hotson A, Chosed R, Shu H, Orth K, Mudgett MB. 2003. Xanthomonas type III effector XopD targets SUMO-conjugated proteins in planta. Mol. Microbiol. 50: 377-389. https://doi.org/10.1046/j.1365-2958.2003.03730.x
Cited by
- Shigella entry unveils a calcium/calpain-dependent mechanism for inhibiting sumoylation vol.6, pp.None, 2017, https://doi.org/10.7554/elife.27444
- The Shigella type three secretion system effector OspF invades host nucleus by binding host importin α1 vol.35, pp.5, 2017, https://doi.org/10.1007/s11274-019-2635-8
- Nuclear trafficking of bacterial effector proteins vol.23, pp.6, 2017, https://doi.org/10.1111/cmi.13320